A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

K, Spencer; V, Souter; N, Tul; R, Snijders; KH, Nicolaides

doi:10.1046/j.1469-0705.1999.13040231.x

Public

A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

Shared by NobleBlocks on Apr 1, 1999 • 12:00 AM UTC

Authors:

Spencer K

Souter V

Tul N

Abstract

Objective To examine the potential impact of combining maternal age with fetal nuchal translucency thickness and maternal serum free beta-human chorionic gonadotropin (beta-hCG) and pregnancy-associated plasma protein-A (PAPP-A) in screening for trisomy 21 at 10-14 weeks of gestation.Methods Materna...

Discussions